NewsRoom Articles - Page 31 of 154 - PsychedelicNewsWire (PNW)

FridayMay 26, 2023 11:14 am

Canadian Survey Reveals Valuable Insights About Psychedelics

Apart from brief research that was carried out in the 1960s, scientists don’t know a lot about the underlying mechanisms that allow psychedelics to deliver their mental health benefits. To help bridge this crucial knowledge gap, several institutions have teamed up to survey the Canadian public on psychedelics. Called the Canadian Psychedelic Survey (CPS), the poll was cosponsored by Psygen Industries, SABI Mind and MAPS PBC, and designed with the aid of academic researchers from top universities and clinicians. The 655-question survey was mainly concerned with collecting data on the characteristics of psychedelics, their patterns of use and public access…

FridayMay 26, 2023 10:30 am

The Green Label Expo: Las Vegas 2023 Edition

The Green Label Expo 2023 edition will be held at the World Market Center in Las Vegas on the 13th & 14th of September, welcoming thousands of CBD experts, alternative product professionals, counterculture experts, and business owners to discover a vast array of global suppliers in trending sectors such as beauty, health & wellness, pet products, foods, business services, and more. As the need for embracing alternative products surges, the vibrant city of Las Vegas is set to welcome the largest trade show for CBD and alternative product professionals. This two-day event will feature an extensive showcase of innovative products/services,…

ThursdayMay 25, 2023 3:54 pm

Legislators Urge HASC to OK Psychedelic Research Targeting PTSD Treatment

A surge in psychedelic research in recent years has revealed something quite interesting: several psychedelic drugs are capable of alleviating symptoms of mental disorders with relatively few side effects. Dubbed the psychedelic renaissance, this movement has seen dozens of researchers across the world focus their attention on determining the possible benefits of leveraging psychedelic therapies in mental health treatment. Given that a large portion of the American population battles with mental illness every day and existing treatments aren’t always effective, safe and efficient psychedelic-assisted therapies will likely aid millions of people in their situations. One of the areas of research…

WednesdayMay 24, 2023 3:33 pm

NIDA Avails $1.5M for Research on Drug Addiction Treatment Using Psychedelics

Decades after lawmakers launched the purported “war on drugs” to curb drug addiction and criminal activity that supported the drug trade, drugs still have a large portion of the American population under their grip. Data from the Association of American Medical Colleges shows that by December 2019, 21 million Americans were suffering from some kind of drug addiction. The stigma around drug addiction and mental health coupled with limited access to adequate treatment facilities means that a majority of Americans with drug addiction fail to receive appropriate care and often suffer adverse health outcomes. However, the past few decades have…

TuesdayMay 23, 2023 3:52 pm

OSU Awarded License to Grow Psilocybin Mushrooms for DEA Research

Research into psychedelics has increased significantly in the recent years, as we learn more about their beneficial properties. Before the psychedelic renaissance, trials on the effectiveness of psilocybin were conducted in the 1960s. However, research grinded to a halt following the classification of the drug as a Schedule I substance. The DEA recently awarded the Ohio State University a license to cultivate hallucinogenic mushrooms for research purposes. This license was awarded to OSU together with a mental health and wellness research and development company focused on psychedelics, Inner State Inc. This makes Ohio State the first university in the country…

MondayMay 22, 2023 12:06 pm

More Firms Enter Psychedelic Field to Develop Mental Health Treatments

Psychedelic reform is gaining traction in the United States as more states introduce measures to decriminalize and legalize the use of these substances. This is primarily due to a significant increase of interest in these drugs in the recent years as more studies uncover the therapeutic benefits that psychedelics possess. Thus far, numerous studies have found that psychedelics such as MDMA, psilocybin and ketamine may help manage symptoms of anxiety and depression, reduce OCD symptoms, improve mood and improve symptoms of post-traumatic stress disorder. In 2017, the FDA even granted breakthrough therapy designations to psychedelic therapies using psilocybin to treat…

FridayMay 19, 2023 11:24 am

Colorado NGO Behind CBD for Pediatric Epilepsy Shifts Attention to Psychedelics Via Sister Organization

Last year, the Stanley Brothers signed a partnership between a professional sports league and a hemp/marijuana brand, becoming the first to do so. Prior to this, the company’s CBD products, including Charlotte’s Web, had been gaining popularity in Colorado, especially after a surge in their use by children with epileptic seizures. Paige Figi, mother to the late Charlotte, who experienced seizures on a daily basis, was the first to discover this benefit. Together with Heather Jackson, whose son also used Charlotte’s Web, Figi founded Realm of Caring to conduct more studies into CBD in 2013. Many years later, medical cannabis…

ThursdayMay 18, 2023 3:19 pm

Five Scientific Discoveries about Psychedelic Substances, Their Effects

Interest in psychedelics has increased significantly in recent years, with numerous studies being conducted on DMT, MDMA, LSD and psilocybin mushrooms. These substances are known to alter cognition, perception and mood when consumed, with researchers finding that they also possess therapeutic benefits that may be useful in the treatment of mental health conditions such as anxiety, depression, addiction and PTSD. Today, we look at some of the discoveries related to psychedelic drugs and their therapeutic potential. Psychedelics may help manage alcohol abuse. One study has determined that a combination of 5-MeO-DMT and ibogaine treatments may help reduce symptoms of PTSD…

WednesdayMay 17, 2023 3:07 pm

Study Identifies Where Psychedelics Users Find Reliable Information

Interest in psychedelics has increased greatly in the last decade or so, as new studies into the treatment of various mental health conditions using these drugs are conducted. As more positive benefits are discovered, we have seen changes to laws that previously prohibited access to the use of psychedelics as well as the emergence of psychedelic NGOs and psychedelic startups. In an effort to inform harm reduction and education programs that address illicit and legal use of psychedelics, researchers looked into information-seeking behaviors of individuals who used psychedelics. The study was led by Dr. Daniel Kruger, a researcher at the…

TuesdayMay 16, 2023 3:48 pm

Beckley Psytech Commences Phase 2a Trial for Treatment-Resistant Depression

Beckley Psytech is a clinical-stage biotechnology company focused on improving the lives of individuals living with neuropsychiatric disorders through the development of psychedelic drugs. In its latest press release, the company revealed that it has administered a new intranasal psychedelic using an FDA-approved delivery device to a patient with treatment-resistant depression during a phase 2a trial. The objective of the phase 2 trial is to assess the effectiveness, safety and pharmacokinetics of the company’s BPL-003 formulation when administered together with psychological support, to patients experiencing moderate to severe symptoms of treatment-resistant depression. BPL-003 is a synthetic formulation of the 5-MeO-DMT…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000